Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy)
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This study will test an investigational drug, theophylline, in children with
pseudohypoparathyroidism type 1a (PHP1a). This study involves a 3 day visit to the Vanderbilt
Clinical Research Center.
Phase:
Phase 2
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center